Analgesic Effect of Intravenous Ketamine in Cancer Patients on Morphine Therapy
- 1 October 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 20 (4) , 246-252
- https://doi.org/10.1016/s0885-3924(00)00194-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Predictive factors and opioid responsiveness in cancer painEuropean Journal Of Cancer, 1998
- Ketamine as an adjunct to morphine in the treatment of painPain, 1995
- Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic painPain, 1995
- Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitizationPain, 1995
- Evidence of a role for (NMDA) receptors in the facilitation of tail withdrawal after spinal transectionPharmacology Biochemistry and Behavior, 1994
- Response of chronic neuropathic pain syndromes to ketamine: a preliminary studyPain, 1994
- Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidencePain, 1993
- Cancer pain: managementThe Lancet, 1992
- The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusionsPain, 1990
- Continuous subcutaneous injection of ketamine for cancer painCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1990